Genentech’s summer of downsizing…
Genentech’s summer of downsizing and cost-cutting continued this morning, with [...]
After an FDA rejection in May,…
After an FDA rejection in May, Stealth BioTherapeutics has resubmitted [...]
Omeros’ efforts to get its…
Omeros’ efforts to get its transplant drug to market have [...]
Experienced business developer…
Experienced business developer Derek Hicks has been handed the reins [...]
Evotec previously planned to lay…
Evotec previously planned to lay off 400 staffers amid a [...]
Prelude Therapeutics’ lead asset…
Prelude Therapeutics’ lead asset won’t be making it to the [...]
Having backed Superluminal…
Having backed Superluminal Medicines’ series A last year, Eli Lilly [...]
Schrödinger is abandoning its…
Schrödinger is abandoning its CDC7 inhibitor after the therapy was [...]
A patient has died from kidney…
A patient has died from kidney injury in a trial [...]
Sarepta Therapeutics is selling…
Sarepta Therapeutics is selling off Arrowhead Pharmaceuticals shares to stretch [...]